Takeaways from this morning's Q and A with Arun~
Pillar "about to be published" but "not promising" it'll be published before SAGES conference.
("It's up to the Journal").
mentioned breast recon at 17-18% / standard of care becoming a "real possibility".
When the agreement with Life Cell expires (end of 2015), Arun will need a better slice of the pie
or else they will not renew. On the other hand, renewing would allow the company to concentrate on their new products, so bottom line: still TBD
Regarding isrg: SPY in 80% of new robots sold in 4Q, 2013
But total firefly sales exceeded robotic sales (I guess this includes customer upgrades)
SPY utilization of existing machines in hospitals now between 55-60%
Arun mentioned (a goal of) sales force between 125/200
Sales of both Pinpoint and Luna going well.
Mentioned a goal of consolidating the sales force
( instead of splitting jobs between capital sales and utilization).
Comfortable with 40% growth this year and in coming years
Some strange stuff going on today. Some large trades this morning with minimum movement, and then all of a sudden, went up to 21.43, and right back down to 21.13 on a couple hundred share trades?? Now under $21
Another item presented that I found interesting was that a second generation PINPOINT device will be revealed at SAGES (April 2-5). Arun intimated that their market strategy included introduction of upgraded versions of current products thus allowing higher pricing power.
Good summary. Like to add that Pillar II has been accepted for publication by a leading Journal but the actual publication date depends on the journal.
Also, there is a corporate presentation dated Feb 2014. Interesting read.